 |
|
|
| |
ELBASVIR/GRAZOPREVIR PLUS SOFOSBUVIR ± RIBAVIRIN IN TREATMENT-NAIVE AND TREATMENT-EXPERIENCED PATIENTS WITH HEPATITIS C VIRUS GENOTYPE 3 INFECTION AND COMPENSATED CIRRHOSIS: THE C-ISLE STUDY
|
| |
| |
Reported by Jules Levin
AASLD 2016 Nov 11-15 Boston, MA
Graham R. Foster*, Kosh Agarwal, Matthew Cramp, Sulleman Moreea, Stephen Barclay, Jane Collier, Ashley S. Brown, Stephen D. Ryder, Andrew Ustianowski, Daniel M. Forton, Ray Fox, Fiona Gordon, William M. Rosenberg, David J. Mutimer, Jiejun Du, Christopher L. Gilbert, Ernest Asante-Appiah, Janice Wahl, Eliav Barr, Barbara Haber
*Queen Mary University, London, United Kingdom
|
| |
|
|
|
|
|
